Melanotan II: difference between revisions
Diff·revision 5 → 6·06:18, 11 Jan 2025
Difference between revision 5 and revision 6 of Melanotan II. 2 lines changed; the page grew by 192 bytes.
| Revision 5 — 15:25, 24 Dec 2024 StubSorterBot (talk) bot: add stub category 2,511 bytes +541 | Revision 6 — 06:18, 11 Jan 2025 TriumphThad (talk) add the stability data with the storage condition it was measured at 2,703 bytes +192 | ||
|---|---|---|---|
| 18 | Melanotan II activates all of these. Selective compounds developed subsequently — [[Bremelanotide|bremelanotide]] for sexual dysfunction, and MC4R-directed agents for genetic obesity — represent the pharmacological correction of that non-selectivity.{{r|hadley2005}} | 18 | Melanotan II activates all of these. Selective compounds developed subsequently — [[Bremelanotide|bremelanotide]] for sexual dysfunction, and MC4R-directed agents for genetic obesity — represent the pharmacological correction of that non-selectivity.{{r|hadley2005}} |
| 19 | 19 | ||
| + | 20 | Effects on appetite are real and are the reason the compound appears in weight-related discussion, but they are accompanied by every other melanocortin effect at the same time.{{r|cone2005}} | |
| + | 21 | ||
| 20 | == References == | 22 | == References == |
| 21 | {{reflist}} | 23 | {{reflist}} |